Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Dettagli Bibliografici
Autori principali:	Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL
Natura:	Conference item
Lingua:	English
Pubblicazione:	Springer 2017

Documenti analoghi

Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
di: Teoh, E, et al.
Pubblicazione: (2017)

Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
di: Scott, NP, et al.
Pubblicazione: (2021)

Cancer imaging with fluciclovine (18F)
di: Teoh, E
Pubblicazione: (2018)

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
di: Morotti, M, et al.
Pubblicazione: (2020)

Glutamine deprivation alters the origin and function of cancer cell exosomes
di: Fan, S, et al.
Pubblicazione: (2020)

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
di: Zuzana Balážová, et al.
Pubblicazione: (2020-04-01)

Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
di: Kirsten Margrete Selnæs, et al.
Pubblicazione: (2020-12-01)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
di: Morotti, M, et al.
Pubblicazione: (2019)

Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
di: Ivar S Jensen, et al.
Pubblicazione: (2020-01-01)

Imaging Glioblastoma With 18F-Fluciclovine Amino Acid Positron Emission Tomography
di: Matthew L. Scarpelli, et al.
Pubblicazione: (2022-01-01)

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas
di: Ephraim E. Parent, et al.
Pubblicazione: (2018-07-01)

Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
di: Tonghe Wang, et al.
Pubblicazione: (2023-12-01)

Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
di: Anna E. Garcia Whitlock, MD, et al.
Pubblicazione: (2020-01-01)

[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis
di: Ephraim E. Parent, et al.
Pubblicazione: (2020-12-01)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
di: Dyer, A, et al.
Pubblicazione: (2018)

Diagnostic accuracy of 18F-Fluciclovine PET/CT in primary lymph node staging of prostate cancer
di: R.J. Hoekstra, et al.
Pubblicazione: (2020-11-01)

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
di: Morteza Esmaeili, et al.
Pubblicazione: (2018-11-01)

The utilisation of glutamine and glucose by a 3-D tumour model trapped in quiescence
di: Smith, H, et al.
Pubblicazione: (2021)

Pharmacodynamic and pharmacokinetic markers for anti-angiogenic cancer therapy: Implications for dosing and selection of patients.
di: Morotti, M, et al.
Pubblicazione: (2017)

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
di: Cato C. Loeff, et al.
Pubblicazione: (2024-11-01)

Quantification of Equivocal Findings in F18-Fluciclovine PET/CT Scans for Biochemical Recurrence of Localized Prostate Cancer
di: Daeun Sung, et al.
Pubblicazione: (2024-05-01)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
di: Giuseppina Biscontini, et al.
Pubblicazione: (2021-02-01)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
di: Tore Bach-Gansmo, et al.
Pubblicazione: (2022-06-01)

Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.
di: Hsiu-Ni Kung, et al.
Pubblicazione: (2011-08-01)

Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction
di: Jun-Kai Yan, et al.
Pubblicazione: (2017-03-01)

Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning
di: Li Ma, et al.
Pubblicazione: (2023-02-01)

Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
di: Benjamin H. Lowentritt, et al.
Pubblicazione: (2020-01-01)

Complement susceptibility in glutamine deprived breast cancer cells
di: Boackle Robert J, et al.
Pubblicazione: (2007-07-01)

Therapeutic Potential of Glutamine Pathway in Lung Cancer
di: Enyu Tang, et al.
Pubblicazione: (2022-02-01)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
di: Hui Li, et al.
Pubblicazione: (2023-06-01)

#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis
di: Breelyn Karno, et al.
Pubblicazione: (2024-04-01)

Texture Analysis in [<sup>18</sup>F]-Fluciclovine PET/CT Aids to Detect Prostate Cancer Biochemical Relapse: Report of a Preliminary Experience
di: Laura Travascio, et al.
Pubblicazione: (2024-04-01)

Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential
di: Wen Zhu, et al.
Pubblicazione: (2024-06-01)

Glutamine and exercise
di: Mioko Nagashima, et al.
Pubblicazione: (2013-11-01)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
di: Rui Ni, et al.
Pubblicazione: (2023-03-01)

Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
di: Andreas Julius Tulipan, et al.
Pubblicazione: (2018-07-01)

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
di: Maria T. Grinde, et al.
Pubblicazione: (2019-05-01)

Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
di: Kawashima, M, et al.
Pubblicazione: (2020)

The duality between two-index potentials and the non-linear sigma model in field theory
di: Zois, I, et al.
Pubblicazione: (1996)

Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein
di: Burcu Yücel, et al.
Pubblicazione: (2022-02-01)